[Studies with Proresid (SP-I) in various innoculation tumors].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002296:Carcinosarcoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D011033:Podophyllin
Untersuchungen mit Proresid (SP-I) bei verschiedenen Impftumoren.